Publications

The CNODES network of researchers, trainees, and analysts conduct studies using administrative healthcare data in response to queries from Canadian regulators. The results of these studies are published in open-access academic journals. CNODES also publishes a selection of its methodological advances, knowledge translation initiatives, and trainee projects.

Leong C, Raymond C, Château D, Dahl M, Alessi-Severini S, Falk J, Bugden S, Katz A. Psychotropic drug use before, during, and after pregnancy: a population-based study in a Canadian cohort (2001-2013). Can J Psychiatry. 2017 Aug;62(8):543-550.

Hicks BM, Yin H, Bladou F, Ernst P, Azoulay L. Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia. Thorax. 2017 Jul;72(7):596-597.

Larivee N, Suissa S, Coulombe J, Tagalakis V, Filion KB. Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: an assessment of risk in first-time users and restarters. Drug Saf. 2017 Jul;40(7):583-596

Falk J, Dahl M, Raymond CB, Chateau D, Katz A, Leong C, Bugden S. Opioid use during pregnancy: a population-based cohort study. CMAJ open. 2017 Jun 26;5(2):E517-E523.

Karim ME, Platt RW; BeAMS study group. Estimating inverse probability weights using super learner when weight-model specification is unknown in a marginal structural Cox model context. Stat Med. 2017 Jun 15;36(13):2032-2047.

Shin J, Eberg M, Ernst P, Filion KB. Statin potency and the risk of hospitalization for community-acquired pneumonia: a population-based nested case-control study. Br J Clin Pharmacol. 2017 Jun;83(6):1319-1327.

Christie R, Sketris I, Andreou P, Holbrook A, Levy A. Does the Number of Pharmacies a Patient Frequents Affect Adherence to Statins? J Popul Ther Clin Pharmacol. 2017 May 6;24(2):e20-e50.

Suissa S, Moodie EE, Dell’Aniello S. Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores. Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):459-468.

Secrest M, Udell JA, Filion KB. The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors. Trends Cardiovasc Med 2017 Apr;27(3):194-202.

Khosrow-Khavar F, Filion KB, Al-Qurashi S, Torabi N, Bouganim N, Suissa S, Azoulay L. Cardiotoxicity of aromatase inhibitors and tamoxifen in post-menopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials. Ann Oncol. 2017 Mar 1;28(3):487-496